Announcements Trials
Browse Landscape

Status

Completed 2Active not recruiting 2Unknown 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 170Observational 5Expanded_access 2

Sponsor

Cancer Type

Myeloid 5

Conditions

Polycythemia Vera 4Primary Myelofibrosis 1Bone Marrow Neoplasms 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × ruxolitinib × Clear all
NCT04217356 2026-01-26

ALLO-BAT

University Health Network, Toronto

Active not recruiting
90 enrolled
Myeloid

Bone Marrow Neoplasms, Primary Myelofibrosis

NCT05548062 2025-09-03

Prospero

Novartis

Active not recruiting
242 enrolled
Myeloid

Polycythemia Vera

NCT05853445 2024-05-06

PAVE

Novartis

Completed
467 enrolled
Myeloid

Polycythemia Vera

NCT05566535 2022-10-04

QoL-PV-R

Multinational Center for Quality of Life Research, Russia

Unknown
32 enrolled
Myeloid

Polycythemia Vera

NCT05421104 2022-07-05

Ruxolitinib for Polycythemia Vera in Patients Resistant to or Intolerant of Hydroxyurea.

Novartis

Completed
1,576 enrolled
Myeloid

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡